Cargando…

Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics

Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid antimicrobial resistance—yet few theoretical models exist for bacterial growth inhibition by a clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment is time...

Descripción completa

Detalles Bibliográficos
Autores principales: Greulich, Philip, Doležal, Jakub, Scott, Matthew, Evans, Martin R, Allen, Rosalind J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730049/
https://www.ncbi.nlm.nih.gov/pubmed/28714461
http://dx.doi.org/10.1088/1478-3975/aa8001
_version_ 1783286291266273280
author Greulich, Philip
Doležal, Jakub
Scott, Matthew
Evans, Martin R
Allen, Rosalind J
author_facet Greulich, Philip
Doležal, Jakub
Scott, Matthew
Evans, Martin R
Allen, Rosalind J
author_sort Greulich, Philip
collection PubMed
description Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid antimicrobial resistance—yet few theoretical models exist for bacterial growth inhibition by a clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment is time-dependent. Here, we use a theoretical model, previously applied to steady-state bacterial growth, to predict the dynamical response of a bacterial cell to a time-dependent dose of ribosome-targeting antibiotic. Our results depend strongly on whether the antibiotic shows reversible transport and/or low-affinity ribosome binding (‘low-affinity antibiotic’) or, in contrast, irreversible transport and/or high affinity ribosome binding (‘high-affinity antibiotic’). For low-affinity antibiotics, our model predicts that growth inhibition depends on the duration of the antibiotic pulse, and can show a transient period of very fast growth following removal of the antibiotic. For high-affinity antibiotics, growth inhibition depends on peak dosage rather than dose duration, and the model predicts a pronounced post-antibiotic effect, due to hysteresis, in which growth can be suppressed for long times after the antibiotic dose has ended. These predictions are experimentally testable and may be of clinical significance.
format Online
Article
Text
id pubmed-5730049
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-57300492017-12-14 Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics Greulich, Philip Doležal, Jakub Scott, Matthew Evans, Martin R Allen, Rosalind J Phys Biol Article Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid antimicrobial resistance—yet few theoretical models exist for bacterial growth inhibition by a clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment is time-dependent. Here, we use a theoretical model, previously applied to steady-state bacterial growth, to predict the dynamical response of a bacterial cell to a time-dependent dose of ribosome-targeting antibiotic. Our results depend strongly on whether the antibiotic shows reversible transport and/or low-affinity ribosome binding (‘low-affinity antibiotic’) or, in contrast, irreversible transport and/or high affinity ribosome binding (‘high-affinity antibiotic’). For low-affinity antibiotics, our model predicts that growth inhibition depends on the duration of the antibiotic pulse, and can show a transient period of very fast growth following removal of the antibiotic. For high-affinity antibiotics, growth inhibition depends on peak dosage rather than dose duration, and the model predicts a pronounced post-antibiotic effect, due to hysteresis, in which growth can be suppressed for long times after the antibiotic dose has ended. These predictions are experimentally testable and may be of clinical significance. 2017-11-16 /pmc/articles/PMC5730049/ /pubmed/28714461 http://dx.doi.org/10.1088/1478-3975/aa8001 Text en http://creativecommons.org/licenses/by/3.0/ Original content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence (http://creativecommons.org/licenses/by/3.0) .
spellingShingle Article
Greulich, Philip
Doležal, Jakub
Scott, Matthew
Evans, Martin R
Allen, Rosalind J
Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title_full Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title_fullStr Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title_full_unstemmed Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title_short Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
title_sort predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730049/
https://www.ncbi.nlm.nih.gov/pubmed/28714461
http://dx.doi.org/10.1088/1478-3975/aa8001
work_keys_str_mv AT greulichphilip predictingthedynamicsofbacterialgrowthinhibitionbyribosometargetingantibiotics
AT dolezaljakub predictingthedynamicsofbacterialgrowthinhibitionbyribosometargetingantibiotics
AT scottmatthew predictingthedynamicsofbacterialgrowthinhibitionbyribosometargetingantibiotics
AT evansmartinr predictingthedynamicsofbacterialgrowthinhibitionbyribosometargetingantibiotics
AT allenrosalindj predictingthedynamicsofbacterialgrowthinhibitionbyribosometargetingantibiotics